Table 4.
Percent Increase (95% CI) in Urinary Arsenicals | ||||
---|---|---|---|---|
U-iAs | U-MMAs | U-DMAs | U-tAs | |
P-iAs1 | 12.9% (2.5, 24.2) | |||
P-MMAs1 | 45.9% (34.8, 57.9) | |||
P-DMAs1 | 47.7% (34.2, 62.5) | |||
P-tAs1 | 49.8% (36.0, 64.9) | |||
Sex | ||||
Males | 0.0% (ref) | 0.0% (ref) | 0.0% (ref) | 0.0% (ref) |
Females | −35.0% (−50.1,−15.3) | −18.6% (−33.1,−0.9) | −26.0% (−41.3,−6.6) | −27.5% (−41.2,−10.6) |
Age | ||||
< 18 | 0.0% (ref) | 0.0% (ref) | 0.0% (ref) | 0.0% (ref) |
18 – 35 | −23.0% (−46.9, 11.5) | −14.0% (−34.5, 12.9) | −17.6% (−40.4, 13.9) | −15.2% (−36.7, 13.6) |
35 – 55 | −16.5% (−43.3, 22.9) | −5.2% (−28.7, 26.0) | −7.5% (−34.1, 29.7) | −7.3% (−31.7, 25.9) |
≥ 55 | 21.1% (−22.8, 90.1) | 28.1% (−8.6, 79.5) | 8.0% (−27.9, 61.7) | 12.9% (−21.4, 62.3) |
BMI | ||||
Underweight | 0.0% (ref) | 0.0% (ref) | 0.0% (ref) | 0.0% (ref) |
Normal | 12.4% (−25.7, 70.0) | −18.0% (−39.5, 11.3) | −2.7% (−32.2, 39.8) | −1.3% (−28.8, 36.9) |
Overweight | 33.2% (−17.1, 114.0) | −25.9% (−47.7, 4.9) | 2.4% (−32.3, 54.8) | 8.6% (−25.3, 57.8) |
Obese | 11.0% (−31.5, 79.8) | −25.4% (−47.7, 6.4) | 8.7% (−28.7, 65.7) | 8.4% (−25.9, 58.7) |
Smoking | ||||
No | 0.0% (ref) | 0.0% (ref) | 0.0% (ref) | 0.0% (ref) |
Yes | 23.8% (−17.6, 86.0) | 2.7% (−24.0, 38.6) | 32.1% (−7.7, 88.9) | 29.4% (−6.3, 78.7) |
Seafood | ||||
Consumption | ||||
No | 0.0% (ref) | 0.0% (ref) | 0.0% (ref) | 0.0% (ref) |
Yes | 28.3% (−9.5, 81.8) | −13.7% (−33.1, 11.4) | 9.1% (−19.4, 47.7) | 13.4% (−13.7, 49.0) |
percent change associated with a doubling of the concentration of plasma arsenicals